Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2006-01-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Replace Glycemic Load and Satiety Study
NCT01516333
UBC Breakfast Study 2.0
NCT06814171
Glycemic Index and CVD: a Crossover Feeding Study
NCT00141076
Effect of Skipping Breakfast on Metabolic Function
NCT02093572
Observational Analysis of the Associational Between Dietary Factors and Postprandial Glucose Fluctuations
NCT07117188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of four isocaloric meals (see example below), varying in macronutrient content and GI value of foods, will be administered in random order at either 8:00 a.m. or 9:00 a.m. Energy density will be controlled. The meal and 8 ounces of water will be consumed within fifteen minutes. A short visual analog questionnaire will be distributed at the conclusion of the meal to rate the meal consumed. Blood samples will be taken 15 minutes after food consumption and at 30 minute intervals (i.e., 30, 60, 90, 120, 150, 180, 210, and 240 minutes) over four hours following administration of the meal. Four milliliters of blood will be collected at each time point (via indwelling catheter), resulting in a total of 40 milliliters of blood collected at each study session and 160 milliliters (i.e., 40 ml x 4 testing sessions) within an 8 week time period. Participants will be asked to rate their feelings of hunger at these time points. Following the last blood sample, participants will be given the opportunity to consume food ad libitum from a buffet style lunch. Based on known serving sizes and measurements of unconsumed food, the amount of food eaten and its associated energy content will be determined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low GI
low GI breakfast
Low GI
low GI, high carb breakfast
Low GI -low carb
Low GI and Low carb breakfast
Low GI Low Carb
low GI low carb breakfast
High GI
High GI breakfast
high GI
high GI and high carb breakfast
High GI Low Carb
high GI low carb breakfast
High GI Low carb
high GI low carb breakfast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high GI
high GI and high carb breakfast
Low GI
low GI, high carb breakfast
Low GI Low Carb
low GI low carb breakfast
High GI Low carb
high GI low carb breakfast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Life Sciences Institute
OTHER
Temple University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary D Foster, PhD
Role: PRINCIPAL_INVESTIGATOR
Temple University - Center for Obesity Research and Education
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Temple University - Center for Obesity Research and Education
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILSI
Identifier Type: -
Identifier Source: secondary_id
10917
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.